Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Epigenetics of myelodysplastic syndromes
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Univers...
Epigenetics of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009
Innovation in the treatment of myelodysplastic syndromes
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Univers...
Innovation in the treatment of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009
Myelodysplastic syndromes (MDS)
Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Univers...
Myelodysplastic syndromes (MDS) ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL...
Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hosp...
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease ( Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital )
30 Apr 2009
AACR 2009: Membrane microfilter device for capture and characterisation of circu...
Anthony Williams - Keck School of Medicine, University of Southern California
AACR 2009: Membrane microfilter device for capture and characterisation of circulating tumour cells ( Anthony Williams - Keck School of Medicine, University of Southern California )
30 Apr 2009
AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia
Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medic...
AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia ( Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medicine, USA )
30 Apr 2009
Bacteria as agents to initiate potent anti-tumour activity
Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of ...
Bacteria as agents to initiate potent anti-tumour activity ( Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan )
31 Mar 2009
Managing cardiotoxicity while treating cancer
Dr Carlo Cipolla - Director of the Cardioncology Division, European Institute of...
Managing cardiotoxicity while treating cancer ( Dr Carlo Cipolla - Director of the Cardioncology Division, European Institute of Oncology, Milan )
18 Mar 2009
Azacitidine for Myelodysplastic Syndrome
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
Azacitidine for Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009
Effects of Myelodysplastic Syndrome
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
Effects of Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009
How azacitidine works
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
How azacitidine works ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009
Myelodysplastic Syndromes and Acute Myeloid Leukaemia
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Cente...
Myelodysplastic Syndromes and Acute Myeloid Leukaemia ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009